Advertisement
- About Us
- Contact
- Editorial Staff
- Editorial Boards
- Advertise
- Do Not Sell My Information
- Terms & Conditions
- Privacy Policy
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial
Published on:
J. Sanford Schwartz, MD, Y. Richard Wang, MD, PhD, John G. F. Cleland, MD, Longlong Gao, MS, Mark Weiner, MD, Philip A. Poole-Wilson, MD, fo
The American Journal of Managed Care, June 2003, Volume 9, Issue 6
Advertisement
Advertisement